Events
LIIARC: Should You Even Bother? Making the Case for Bringing a Case
Tuesday 24 November 2026 | 6pm - 7.30pm followed by drinks
Wilberforce Chambers, 77 Chancery Lane
Civil fraud and asset recovery, Commercial disputes, Company law, International / offshoreTuesday 15 October 2024
Commercial Court grants Norwich Pharmacal order in Filatona Trading and Oleg Deripaska v Quinn Emanuel Urquhart & Sullivan UK
On 14 October 2024 the Commercial Court handed down judgment in Filatona Trading Limited and Oleg Deripaska v Quinn Emanuel Urquhart & Sullivan UK LLP [2024] EWHC 2573 (Comm). Mr Justice Calver acceded to the Claimants’ application for a Norwich Pharmacal order where the defendant law firm had obtained from an unnamed business consultancy a report which was subsequently deployed in s.68 proceedings against the Claimants with a view to setting aside an arbitration award. The report was subsequently revealed to be a forgery. The judgment contains a very interesting analysis of the circumstances in which a law firm might become amenable to a Norwich Pharmacal order and the extent to which privilege might bar such relief.
Thomas Grant KC led James Sheehan KC of Essex Court Chambers, who were instructed by Mark Hastings, Abigail Healey and Emma Kingstone of Quillon Law.
People to view:
Related Insights View all thought leadership
Articles
Foreign judgments and issue estoppel: orthodoxy reasserted
In the latest edition of our commercial litigation insights series, Andreas Giannakopoulos examines the Court of Appeal's recent decision in Aviator LLC v Spribe OÜ [2026] EWCA Civ 1224, considering whether the preclusive effect of a foreign judgment on a claim made in subsequent English proceedings is governed by English law or the law applicable to the underlying claim.
By Andreas Giannakopoulos
View more
Wednesday 28 October 2026News
Clare Stanley KC featured in Chambers & Partners Stars at the Bar 2027
Clare Stanley KC has been named as one of Chambers’ Stars at the Bar, an accolade given to just 16 top barristers who are recognised for their excellence across a range of practice areas. Clare is ranked by Chambers &... Read more
Tuesday 27 October 2026
View more
Articles
A fiduciary’s duty to disclose: a shield, not a sword?
In this article in our commercial litigation insights series, Alice Hawker examines the Court of Appeal's recent decision in G.I. Globinvestment Ltd v XY ERS UK Limited [2026] EWCA Civ 1248, considering whether a fiduciary's duty to disclose is a shield (against claims alleging breach of the ’no conflict’ or ’no profit’ rules) or a sword (to be used as a freestanding claim).
By Alice Hawker
View more
Monday 19 October 2026
